Ricardo Hermosilla

Ricardo Hermosilla is a seasoned drug development expert today working as an independent preclinical and clinical consultant for biotech and pharma companies. Before his consultancy, he worked for several departments at F. Hoffmann-La Roche, i.e., Cardiovascular & Metabolism, Neuroscience, Ophthalmology, and Rare Diseases. In his last position at Hoffmann-La Roche as Project Team Leader and Translational Medicine Leader in the Department of Neuroscience, Ophthalmology, and Rare Diseases, he was, among others, responsible for the development of innovative strategies, supporting research teams from non-clinical to clinical development, and leading clinical development plans and trial protocols. Prior to that, he held various roles such as Head of Study Directors, COO, Medical Director, Head of Clinical Development in Biotechs, midsize Pharma and a CRO. Ricardo started his career in academia at the University of Chile and as a Post Doc at the Research Institute for Molecular Pharmacology (FMP Berlin), before he was appointed as Junior-Professor at the Charité in Berlin. Besides his consultancy activities, he is an advisory board member for startups and NGOs and a guest professor at the University Austral, Chile. Ricardo Hermosilla holds PhD in Molecular Pharmacology from Justus-Liebig-University.